Experiment summary for ENCSR000EZP
doi:10.17989/ENCSR000EZP
Summary
- Status
- released
- Assay
- ChIP-seq (TF ChIP-seq)
- Target
- SREBF1
- Biosample summary
- Homo sapiens HepG2 treated with 2 μM pravastatin for 16 hours
- Biosample Type
- cell line
- Replication type
- isogenic
- Description
- SREBF1 ChIP-seq on human HepG2 treated with pravastatin
- Treatments
- 2 μM pravastatin (CHEBI:63618) for 16 hours
- Nucleic acid type
- DNA
- Fragmentation methods
- see document
- Platform
- Illumina Genome Analyzer
- Controls
Attribution
ENCODE2 project
- Lab
- Sherman Weissman, Yale
- Award
- U54HG004558 (Michael Snyder, Stanford)
- Project
- ENCODE
- External resources
- Date submitted
- December 2, 2010
- Date released
- October 29, 2011
- Annotation (gkmsvm-model)
- Tags
- Factorbook
Encyclopedia Integration
Isogenic replicates
Isogenic replicate | Technical replicate | Summary | Biosample | Antibody | Library |
|---|---|---|---|---|---|
| 2 | 1 | Homo sapiens HepG2 cell line treated with 2 μM pravastatin for 16 hours | ENCBS712AAA | ENCAB000ALC | ENCLB723GUY |
| 3 | 1 | Homo sapiens HepG2 cell line treated with 2 μM pravastatin for 16 hours | ENCBS712AAA | ENCAB000ALC | ENCLB723GUZ |
| 1 | 1 | Homo sapiens HepG2 cell line treated with 2 μM pravastatin for 16 hours | ENCBS712AAA | ENCAB000ALC | ENCLB723GVA |